B

Halozyme Therapeutics, Inc. HALO

NASDAQ
Recommendation
Dividend Power Score
Day's Range
$95.01$97.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
My Lists My Alerts

09/30/2026 06/30/2026 03/31/2026 12/31/2025 09/30/2025
Net Income 7.45% 53.23% 205.97% -180.81% 6.09%
Total Depreciation and Amortization 0.68% 0.69% 26.44% 30.66% -0.40%
Total Amortization of Deferred Charges -1.55% 0.40% 15.13% 4.95% 0.32%
Total Other Non-Cash Items -35.41% -9.52% -94.07% 767.12% 833.92%
Change in Net Operating Assets 14.99% -66.29% -177.84% 83.82% 36.67%
Cash from Operations 7.21% 33.77% -17.78% 22.64% 79.11%
Capital Expenditure 26.91% -11.55% -162.16% 52.90% -93.86%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -100.00% 100.10% -- --
Divestitures -- -- -- -- --
Other Investing Activities 141.03% -38,080.52% 101.07% -107.03% 136.99%
Cash from Investing 133.43% -2,078.07% 99.61% -467.93% 137.78%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 368.61% -- -- -74.84% 1,271.13%
Repurchase of Common Stock 79.68% -20,427.96% -- 100.00% 87.05%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 280.12% -20,126.35% -100.67% 1,169.17% 92.51%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 685.63% -184.30% 161.99% -179.16% 412.58%